Abstract
A 34-year-old woman with fulminant myocarditis underwent emergent implant with the Toyobo (Nipro, Osaka, Japan) paracorporeal biventricular assist device (BiVAD). The patient had been stable for 6 months, until she started to develop heart failure symptoms due to severe pulmonary insufficiency. Pulmonary valve closure and BiVAD conversion to implantable rotary pumps was performed. A DuraHeart centrifugal pump (Terumo Heart Inc., Ann Arbor, MI) was used for left ventricular assist, and a Jarvik 2000 axial-flow pump (Jarvik Heart Inc., New York, NY) was used for right ventricular assist. Although strict management was required to balance the flow rates of the two different types of devices, her postoperative course was uneventful and she was discharged home.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
